CHROMID MRSA SMART | 合法醫療器材資訊網

Multi-drug resistant organisms[1] (MDRO) and related risk of healthcare associated infection (HAI) outbreaks are among today’s most challenging public health issues. bioMérieux has an overall commitment to helping address these challenges in innovative ways, such as with our AMS Program[2] initiative and our SMART range of media, which is developed specifically to target pathogens involved. Methicillin-resistant Staphylococcus aureus (MRSA) are a prime concern – listed as a “serious threat” by the Centers for Disease Control1. MRSA (and other Staphylococci) cause a range of infections including pneumonia and bloodstream infections that can lead to sepsis. Rapid identification of MRSA is therefore essential to improved patient care, and infection control and outbreak management.

1. Antibiotic Resistance Threats in the United States, CDC 2019